Werba Rubin Papier Wealth Management Buys 437 Shares of Agilent Technologies, Inc. (NYSE:A)

Werba Rubin Papier Wealth Management raised its position in shares of Agilent Technologies, Inc. (NYSE:A) by 16.5% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,081 shares of the medical research company’s stock after acquiring an additional 437 shares during the period. Werba Rubin Papier Wealth Management’s holdings in Agilent Technologies were worth $457,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Crewe Advisors LLC raised its holdings in shares of Agilent Technologies by 114.8% in the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after buying an additional 101 shares during the period. Ridgewood Investments LLC purchased a new stake in Agilent Technologies in the second quarter worth $29,000. Riverview Trust Co bought a new stake in shares of Agilent Technologies during the first quarter worth $41,000. Larson Financial Group LLC boosted its stake in shares of Agilent Technologies by 29,300.0% during the first quarter. Larson Financial Group LLC now owns 294 shares of the medical research company’s stock valued at $43,000 after purchasing an additional 293 shares during the period. Finally, Ashton Thomas Private Wealth LLC bought a new position in shares of Agilent Technologies in the second quarter worth about $39,000. Institutional investors own 87.42% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on A. TD Cowen boosted their price objective on shares of Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. Citigroup raised their price objective on Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Wolfe Research cut Agilent Technologies from an “outperform” rating to a “peer perform” rating in a report on Thursday, June 27th. Evercore ISI raised their price target on Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. Finally, UBS Group lifted their price objective on Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $144.36.

Agilent Technologies Price Performance

NYSE A opened at $138.83 on Friday. The firm’s fifty day simple moving average is $141.02 and its two-hundred day simple moving average is $138.77. The firm has a market capitalization of $40.51 billion, a P/E ratio of 32.82, a P/E/G ratio of 6.96 and a beta of 1.05. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. Agilent Technologies, Inc. has a 12-month low of $96.80 and a 12-month high of $155.35.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.06. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The firm had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the previous year, the business earned $1.43 EPS. The firm’s revenue for the quarter was down 5.6% on a year-over-year basis. Analysts forecast that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st will be given a $0.236 dividend. This represents a $0.94 annualized dividend and a dividend yield of 0.68%. The ex-dividend date is Tuesday, October 1st. Agilent Technologies’s payout ratio is currently 22.22%.

Insiders Place Their Bets

In related news, SVP Dominique Grau sold 9,990 shares of the company’s stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the transaction, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at $5,801,595. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total transaction of $283,910.00. Following the completion of the sale, the chief executive officer now directly owns 24,118 shares in the company, valued at approximately $3,497,110. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Dominique Grau sold 9,990 shares of the stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the sale, the senior vice president now owns 40,011 shares in the company, valued at $5,801,595. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 13,953 shares of company stock valued at $2,013,630. Insiders own 0.33% of the company’s stock.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.